Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence-Reference-Cited by-同舟云学术

Hypertension and COVID-19: Potential use of beta-blockers and a call for randomized evidence

Published:2021-11 Issue:6 Volume:73 Page:757-759
ISSN:0019-4832
Container-title:Indian Heart Journal
language:en
Short-container-title:Indian Heart Journal

Author:

Alsagaff Mochamad Yusuf^ORCID,Mulia Eka Prasetya Budi^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?;Fang;Lancet Respir Med,2020

2. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy;Grasselli;JAMA - J Am Med Assoc,2020

3. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression;Pranata;JRAAS - J Renin-Angiotensin Aldosterone Syst,2020

4. ESC/ESH Guidelines for the management of arterial hypertension;Williams;Eur Heart J,2018

5. The potential benefit of beta-blockers for the management of COVID-19 protocol therapy-induced QT prolongation: a literature review;Heriansyah;Sci Pharm,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of COVID-19 infection in patients on antihypertensives: A cross-sectional study;World Journal of Critical Care Medicine;2024-09-09

2. Cardiovascular medications and its relations with COVID-19 survival;COVID-19’s Consequences on the Cardiovascular System;2024

3. Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study;Frontiers in Pharmacology;2023-12-05

4. Distinct Features of Vascular Diseases in COVID-19;Journal of Inflammation Research;2023-07

5. Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages;Heliyon;2023-03